Carter Bankshares, Inc. (CARE) Stock Price & Analysis
Carter Bankshares, Inc. (CARE) closed at USD 30.22 on Wednesday, October 28, 2026, down 0.33% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 30.32; the Oct 28, 2026 session ranged USD 29.88–30.38 on volume of 135,142 shares. Market capitalization is $700.01M, with a 52-week range of USD 16.78–36.06 (NMS). Source: Nexqual, retrieved October 29, 2026 at 12:15 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CARE.md
Key facts (CARE)
- Last four reported quarters (through Jun 30, 2026): revenue $255M, net income $129M (50.5% margin) (SEC filings).
- Valuation: P/E 5.4x (avg 15.1x at the last 3 fiscal year-ends).
- Insider open-market sales, last ~7 months: 5 Form 4 filings, $341K; 5 not under a Rule 10b5-1 plan ($341K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $120K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.75 on a 1–5 scale) (4 analysts), mean target USD 35.08 (range 34.5–35.75).
- Total return with dividends: 1Y +75.2% vs S&P 500 +13.6%; 5Y +103.1% vs S&P 500 +79.8%.
- Next earnings: 2026-10-29, EPS estimate USD 0.53, revenue estimate $45.4M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CARE)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $140M | $162M | $141M | $136M | $153M | $255M |
| Net income | $31.6M | $50.1M | $23.4M | $24.5M | $31.4M | $129M |
| EPS (diluted) | $1.19 | $2.03 | $1.00 | $1.06 | $1.38 | — |
| Free cash flow | $69.1M | $64.9M | $36.9M | $28.8M | $31.8M | $58.8M |
| Net margin | 22.6% | 31.0% | 16.6% | 18.1% | 20.5% | 50.5% |
| Revenue growth | +6.4% | +15.4% | -13.0% | -3.4% | +12.8% | — |
| Cash + short-term investments | $278M | $46.9M | $54.5M | $131M | $105M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CARE)
P/E 5.4x · P/S 2.8x · P/FCF 11.9x · P/B 1.3x · FCF yield 8.39% · Earnings yield 18.37%
P/E at fiscal year-ends: Dec 2025 14.1x, Dec 2024 16.4x, Dec 2023 14.9x.
Insider sales (SEC Form 4, open-market, last ~7 months) (CARE)
0 of 5 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Midkiff Catharine L. | Director | 1,000 | $31K | 5.2% | No | Too little history (no open-market trades in 2024) |
| 2026-07-30 | Bolton Robert M. | Director | 1,500 | $52K | 2.2% | No | Too little history (no open-market trades in 2024) |
| 2026-07-30 | Langs Bradford N. | PRESIDENT, CHIEF STRATEGY OFCR | 2,500 | $86K | 7% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-05-12 | Langs Bradford N. | PRESIDENT, CHIEF STRATEGY OFCR | 5,500 | $146K | 16.9% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-05-05 | Haskins James W. | Director | 1,000 | $26K | 1.5% | No | Too little history (no open-market trades in 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (CARE)
1 purchase, $120K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-05-06 | Walsh Elizabeth L. | Director | 4,575 | $120K | 26.2 | Too little history (no open-market trades in 2023–2025) |
Analysts (CARE)
Consensus Hold (mean 2.75 on a 1–5 scale), 4 analysts; mean target USD 35.08 (low 34.5, high 35.75).
Total return (dividends reinvested) (CARE)
| 1Y (from 2025-10-29) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +75.2% | +103.1% |
| S&P 500 (SPY) | +13.6% | +79.8% |
| Per year | +75.5% | +15.2% |
| Volatility (annualized) | 24.9% | 28.6% |
| Max drawdown | -16.7% (Aug 2026→Sep 2026) | -41.7% (Nov 2022→Oct 2023) |
CARE earnings history and stock reaction
| Results filed | Quarter | EPS | Consensus | Surprise | Stock reaction |
|---|---|---|---|---|---|
| — | Quarter ended Jun 30, 2026 | $0.53 | $0.43 | Beat +23.3% | — |
| — | Quarter ended Mar 31, 2026 | $0.40 | $3.91 | Miss −89.8% | — |
| — | Quarter ended Dec 31, 2025 | $0.41 | $0.35 | Beat +17.1% | — |
| — | Quarter ended Sep 30, 2025 | $0.26 | $0.41 | Miss −36.6% | — |
EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).
CARE recent SEC filings (last 120 days)
| Filed | Form | What it says |
|---|---|---|
| Oct 29, 2026 | 8-K | Other material event “On October 29, 2026, Carter Bankshares, Inc. (the "Company") (NASDAQ: CARE), the holding company of Carter Bank (the "Bank"), issued a press release announcing that its Board of Directors declared a quarterly cash dividend of $0.10 per share on October 28, 2026. The dividend is payable on November 23, 2026 to shareholders of record as of November 9, 2026. Based on the closing stock price on October 28, 2026 of $30.22, the annualized dividend yield is 1.32%. A copy of the Company's press release dated October 29,…” |
| Oct 29, 2026 | 8-K | Quarterly results |
| Oct 8, 2026 | Schedule 13G/A | Dimensional Fund Advisors LP: 6.2% of shares, passive 5%+ holder (amended) |
| Aug 17, 2026 | 8-K | Other material event “On August 17, 2026, Carter Bankshares, Inc. (the "Company") and its wholly-owned subsidiary, Carter Bank & Trust (the "Bank"), announced that the lawsuit filed against the Company and the Bank (along with certain other unaffiliated persons and entities) in the Circuit Court of Greenbrier County, West Virginia, by James C. Justice, II, his son James C. Justice, III, his daughter Jillean L. Justice, and various related entities that he and/or they own or in which they have an investment (collectively, the "Justice…” |
| Aug 14, 2026 | Schedule 13G/A | Fourthstone LLC, Fourthstone Master Opportunity Fund Ltd: 0.0% of shares, passive 5%+ holder (amended) |
| Aug 11, 2026 | 8-K | Other material event “The Board of Directors of Carter Bankshares, Inc. (the "Company") has established the Carter Bankshares, Inc. Dividend Reinvestment and Stock Purchase Plan (the "Plan"). The Company will offer up to 1,000,000 shares of common stock, par value $1.00 per share (the "Common Stock"), to existing shareholders of the Company for purchase under the Plan. The Plan provides enrolled participants with the opportunity to purchase additional shares of Common Stock through the reinvestment of dividends and through additional…” |
| Aug 6, 2026 | 10-Q | Quarterly report · period ended Jun 30, 2026 |
| Jul 31, 2026 | Schedule 13G/A | Vanguard Capital Management: 5.0% of shares, passive 5%+ holder (amended) |
| Jul 27, 2026 | 8-K | Regulation FD disclosure |
| Jul 23, 2026 | 8-K | Other material event “On July 23, 2026, Carter Bankshares, Inc. (the "Company") (NASDAQ: CARE), the holding company of Carter Bank (the "Bank"), issued a press release announcing that its Board of Directors declared a quarterly cash dividend of $0.10 per share. The dividend is payable on August 24, 2026 to shareholders of record as of August 10, 2026. Based on the closing stock price on July 22, 2026 of $32.92, the annualized dividend yield is 1.22%. A copy of the Company's press release dated July 23, 2026 is attached as Exhibit 99 to…” |
| Jul 23, 2026 | 8-K | Quarterly results |
Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.
CARE suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Federal Deposit Insurance | “If the Company fails to meet applicable capital or liquidity requirements, it could become subject to supervisory actions or enforcement measures, including restrictions on our operations or growth, and such failure could affect customer confidence, our cost of funds and FDIC insurance costs, our ability to pay dividends, our ability to accept brokered deposits and our ability to make acquisitions, among other thi…” |
Quoted from the company's 10-K filed Mar 5, 2026.
CARE analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.53 | $0.53 | -0.6% | $45.4M | 4 |
| Next quarter (ends Dec 2026) | $0.56 | $0.57 | -0.3% | $46.8M | 4 |
| Current fiscal year (ends Dec 2026) | $5.76 | $5.50 | +4.9% | $259.5M | 3 |
| Next fiscal year (ends Dec 2027) | $2.60 | $2.57 | +1.3% | $204.1M | 4 |
Key Statistics (as of October 29, 2026 at 12:15 UTC)
| Price | USD 30.22 |
|---|---|
| Change | ▼ 0.33% (down) |
| Previous Close | USD 30.32 |
| Open | USD 30.36 |
| Day Range | USD 29.88 – 30.38 |
| 52-Week Range | USD 16.78 – 36.06 |
| Volume | 135,142 shares |
| Market Cap | $700.01M |
| Exchange | NMS |
Technical Analysis (CARE)
Nexqual's technical model rates CARE "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 29, 2026 at 12:15 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.3 (neutral) |
| vs SMA50 | Below (USD 30.72) |
| MACD | -0.09 (negative) |
Analyst Ratings (CARE)
Wall Street analysts rate CARE "Hold" based on 4 analysts, with a mean price target of USD 35.08 (range USD 34.5–35.75), per Nexqual as of October 29, 2026 at 12:15 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 35.08 |
| High Target | USD 35.75 |
| Low Target | USD 34.5 |
| Buy / Hold / Sell | 1 / 3 / 0 |
Earnings (CARE)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.53 |
| Revenue Estimate | $45.36M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.53 vs est 0.43 ▲ beat |
| 2026-03-31 | USD 0.4 vs est 3.91 ▼ miss |
| 2025-12-31 | USD 0.41 vs est 0.35 ▲ beat |
| 2025-09-30 | USD 0.26 vs est 0.41 ▼ miss |
Source: Nexqual, October 29, 2026 at 12:15 UTC.
Financials & Fundamentals (CARE)
| Total Revenue | $286.21M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +68.30% |
| Gross Margin | +0.00% |
| Operating Margin | +55.04% |
| Profit Margin | +44.92% |
| ROE | +27.22% |
| Total Cash | $219.47M |
| Total Debt | $11.39M |
Source: Nexqual, October 29, 2026 at 12:15 UTC.
Financial Health Score (CARE)
Nexqual rates Carter Bankshares, Inc.'s overall financial health "Strong" across five dimensions, as of October 29, 2026 at 12:15 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Strong — Net margin 51% (last 12 months); banks have no gross margin |
| Balance Sheet | N/A — Not comparable for banks: deposits and customer funds sit on the balance sheet, so cash vs debt does not measure safety (SEC industry: National Commercial Banks) |
| Cash Flow | N/A — Not meaningful for banks and lenders: lending and trading move operating cash flow by billions each year (SEC industry: National Commercial Banks) |
| Efficiency | Strong — ROE 24%, ROA 2.7% (last 4 quarters, SEC) |
Ownership (CARE)
| Insider Ownership | +2.28% |
|---|---|
| Institutional Ownership | +67.99% |
| Shares Outstanding | 23.16M |
| Float | 21.24M |
| Short % of Float | +10.99% |
Source: Nexqual, October 29, 2026 at 12:15 UTC.
Leadership (CARE)
Carter Bankshares, Inc. is led by Litz H. Van Dyke, CEO & Director, per Nexqual as of October 29, 2026 at 12:15 UTC.
| CEO & Director | Litz H. Van Dyke |
|---|---|
| Vice Chairman | Phyllis Q. Karavatakis |
| Senior EVP & Chief Financial Officer | Wendy S. Bell |
| Executive VP & Director of Regulatory Risk Management | A. Loran Adams |
| Senior Vice President of Commercial Banking | Jayson Philbeck |
Major Backers & Investors (CARE)
Notable institutional backers of Carter Bankshares, Inc. include American Century Companies Inc, Lazard Asset Management LLC, Fidelity, according to Nexqual as of October 29, 2026 at 12:15 UTC.
Active Investors
| Investor | Stake |
|---|---|
| American Century Companies Inc | 3.2% |
| Lazard Asset Management LLC | 2.89% |
| Fidelity | 2.45% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 1.94% |
| Acadian Asset Management. LLC | 1.75% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.11% |
| Dimensional Fund Advisors | 5.67% |
| Vanguard Group | 4.31% |
| State Street | 4.12% |
| Geode Capital | 2.6% |
Source: Nexqual, October 29, 2026 at 12:15 UTC.
From Carter Bankshares, Inc.'s Latest SEC 10-K Filing (filed 2026-03-05)
Partnerships
- If a financial holding company ceases to meet these capital and management requirements, the FRB's regulations provide that the financial holding company must enter into an agreement with the FRB to comply with all applicable capital and management requirements.
Legal & Regulatory Risks (Item 1A, quoted)
- The Company is subject to extensive regulation and supervision, and changes in laws or regulatory expectations could materially adversely affect its business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FITB | Fifth Third Bancorp | USD 53.47 | ▼ 0.22% |
| NU | Nu Holdings Ltd. | USD 11.97 | ▼ 3.47% |
| TFC | Truist Financial Corporation | USD 48.42 | ▼ 0.25% |
| DB | Deutsche Bank AG | USD 33.51 | ▲ 4.33% |
| NWG | NatWest Group plc | USD 17.23 | ▲ 2.13% |
| LYG | Lloyds Banking Group Plc | USD 5.5 | ▲ 1.85% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 12:15 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt